- Report
- October 2023
- 146 Pages
Global
From €3229EUR$3,528USD£2,708GBP
€3799EUR$4,150USD£3,186GBP
- Report
- August 2024
- 105 Pages
Global
From €3500EUR$4,096USD£3,038GBP
- Report
- March 2024
- 122 Pages
Global
From €3500EUR$4,096USD£3,038GBP
- Report
- May 2025
- 88 Pages
Global
From €3500EUR$4,096USD£3,038GBP
- Report
- February 2024
- 132 Pages
Global
From €870EUR$950USD£729GBP
- Report
- September 2024
- 280 Pages
Global
From €1701EUR$1,859USD£1,427GBP
€2430EUR$2,655USD£2,038GBP
- Book
- August 2025
- 576 Pages
- Book
- August 2024
- 416 Pages
- Book
- September 2021
- 576 Pages
- Book
- April 2021
- 6032 Pages
€4114EUR$4,651USD£3,333GBP

High Throughput Screening (HTS) is a technology used in the diagnostics market to rapidly identify compounds that interact with a target of interest. HTS is used to identify potential drug candidates, biomarkers, and other molecules that can be used in diagnostics. It is a powerful tool for drug discovery and development, as it can quickly identify compounds that interact with a target of interest. HTS can also be used to identify potential biomarkers for diagnostics, as it can quickly identify molecules that interact with a target of interest.
HTS is used in a variety of diagnostic applications, including cancer diagnostics, infectious disease diagnostics, and genetic diagnostics. HTS can be used to identify potential drug candidates, biomarkers, and other molecules that can be used in diagnostics.
Some companies in the HTS market include Agilent Technologies, Bio-Rad Laboratories, PerkinElmer, and Thermo Fisher Scientific. Show Less Read more